|
2025
|
G/S
|
Produits pharmaceutiques et vétérinaires; vaccins; désinfectants, antibactériens, anti-allergènes... |
|
|
Invention
|
Class i lanthipeptides with anti-viral function. Here, the inventors use genomics to discover a n... |
|
|
Invention
|
Modulators of fam118b protein for use in therapy. The invention relates to the human protein Fami... |
|
|
Invention
|
Apsab combines a nuclease/helicase protein and an argonaute-like protein to cleave dna. The inven... |
|
|
Invention
|
Variants of terminal deoxynucleotidyl transferase and uses thereof.
The present invention relate... |
|
|
Invention
|
Mopevac-based plateform for heterologous orf(s) expression. The invention relates to nucleic acid... |
|
|
Invention
|
Ingrilimine and derivatives, involvement in neurodegenerative diseases. 1234523231677 represent i... |
|
|
Invention
|
Ripk3-induced cell death of malignant b cells. The invention relates to the field of cancer thera... |
|
|
Invention
|
Ravidasvir, velpatasvir, and elbasvir for blocking transmission of plasmodium gametocytes. Plasmo... |
|
2024
|
Invention
|
Immunocytokine for cancer treatment. The invention relates to immunocytokines comprising an anti-... |
|
|
Invention
|
Nucleic acid vaccine against the sars-cov-2 coronavirus.
The invention relates to an immunogenic... |
|
|
Invention
|
Methods and reagents for detecting piperaquine-resistant plasmodium falciparum malaria.
A method... |
|
|
Invention
|
Engineered phagemids and methods for antibacterial peptide delivery against bacterial pathogens i... |
|
|
Invention
|
Nucleic acid vaccine against the sars-cov-2 coronavirus. The invention relates to an immunogenic ... |
|
|
Invention
|
Method for visualizing at least a zone of an object in at least one interface.
The invention con... |
|
|
Invention
|
Antibodies directed to ace2 and their use as medicine. The present invention relates to anti-ACE2... |
|
|
Invention
|
Novel nanoparticles of antiretroviral drugs, their preparation and their use for the treatment of... |
|
|
Invention
|
Anellovirus genome quantification as a biomarker of immune suppression.
The present invention re... |
|
|
Invention
|
Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant ... |
|
|
Invention
|
Microfluidic device for studying and/or manipulating a study medium and/or at least one micro-obj... |
|
|
Invention
|
Single domain antibodies directed against human transmembrane- serine protease 2 (tmprss2). The i... |
|
|
Invention
|
Heterodimer of poxvirus a16 and g9 proteins as an immunogen. The invention relates to an isolated... |
|
|
Invention
|
Tumor specific antigens and uses thereof. The present invention relates to novel tumor specific p... |
|
|
Invention
|
Recombinant protein, expression cassette, immunogenic composition and use thereof. The present in... |
|
|
Invention
|
Method for identifying abnormalities in cells of interest in a biological sample. This invention ... |
|
|
Invention
|
Combined antibodies against sarbecoviruses and uses thereof. The invention relates to combined an... |
|
|
Invention
|
Adeno-associated virus vector encoding connexin 26 and uses thereof. The present invention relate... |
|
|
Invention
|
Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus... |
|
|
Invention
|
Bacteriophage therapy.
The subject invention provides a pharmaceutical composition comprising: (... |
|
|
Invention
|
Broadly sars-cov-2 neutralizing monoclonal antibodies and uses thereof. The invention relates to ... |
|
2023
|
Invention
|
A method for identifying genomic interactions. The present invention relates to an in vitro metho... |
|
|
Invention
|
Lachnospiraceae spp and ruminococcus lactaris strains for the treatment and prevention of alzheim... |
|
|
Invention
|
Identifying the minimal catalytic core of dna polymerase d and applications thereof.
The inventi... |
|
|
Invention
|
Method for identifying abnormalities in cells of interest in a biological sample.
A computer-imp... |
|
|
Invention
|
Multivalent mopevac-based immunogenic composition for vaccination against new world arenaviruses ... |
|
|
Invention
|
Compositions comprising a botanical extract as insecticidal agent.
A composition comprising an o... |
|
|
Invention
|
Method for reprogramming cd8+ t cells to enhance their therapeutic potential and applications the... |
|
|
Invention
|
Boosting sars-cov-2 immunity with a lentiviral-based nasal vaccine.
The invention relates to the... |
|
2022
|
Invention
|
Medical device for the targeted application of a therapeutic agent to the round window of the coc... |
|
|
Invention
|
Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in... |
|
|
Invention
|
Dual recombinant aav8 vector system encoding isoform 5 of otoferlin and uses thereof.
A dual AAV... |
|
|
Invention
|
Luminescent based antigen assay.
System for detecting an antigen comprising: —a first fusion pro... |
|
|
Invention
|
In vitro generation of organized 3d cell structures including head-trunk embryo-like structures, ... |
|
|
Invention
|
Single domain antibody specific for phosphorylated h2ax and its uses.
The present invention rela... |
|
|
Invention
|
Lentiviral vector, lentiviral particle for treating hepatitis b and its preparation method and ap... |
|
|
Invention
|
Human neutralizing monoclonal antibodies against sars-cov-2 and uses thereof.
The invention rela... |
|
|
Invention
|
Lentiviral vectors targeting antigens to mhc-ii pathway and inducing protective cd8+ and cd4+ t-c... |
|
2020
|
Invention
|
Live imaging system to visualize the retro-transcribed viral dna genome.
A recombinant lentivira... |
|
|
G/S
|
Scientific research instruments and apparatus for laboratories, namely, photographic equipment fo... |
|
|
G/S
|
Scientific research instruments and apparatus for
laboratories; downloadable computer software a... |
|
2019
|
G/S
|
Chemical and biological preparations and substances for
scientific and pharmaceutical industry; ... |
|
|
G/S
|
Chemical and biological preparations and substances intended
for science and the pharmaceutical ... |
|
2012
|
G/S
|
Vaccines for diseases notably cancer, AIDS, plague, rabies, malaria, hepatitis, dengue fever, flu... |
|
2009
|
G/S
|
Paper, cardboard and goods made from these materials, not
included in other classes, namely pack... |
|
2008
|
G/S
|
Paper, cardboard and goods made of these materials, not
included in other classes, namely packag... |
|
2000
|
G/S
|
Bleaching preparations and other substances for laundry use;
preparations for cleaning, polishin... |
|
1999
|
G/S
|
Chemicals used in industry, science, photography, as well as
in agriculture, horticulture and fo... |
|
1998
|
G/S
|
Préparations pharmaceutiques, nommément médicaments pour le traitement et la prévention de divers... |
|
|
G/S
|
Services éducatifs nommément, organisation et conduite de colloques, conférences, expositions et ... |
|
1993
|
G/S
|
periodical publications; namely, scientific journals, research reports and research activity repo... |
|
1987
|
G/S
|
Produits chimiques destinés à l'industrie, aux sciences. Produits pharmaceutiques, vétérinaires. |
|
1986
|
G/S
|
Heat-stable vaccine against yellow fever. |
|
|
G/S
|
Produits pharmaceutiques, vaccin et, plus particulièrement,
vaccin antigrippal. |
|
1984
|
G/S
|
Réactifs de laboratoires à usage biomédical. Produits pharmaceutiques et vétérinaires. |
|
1975
|
G/S
|
Produits chimiques destinés à l'industrie, la science, la
photographie, l'agriculture, l'horticu... |
|
1972
|
G/S
|
Préparations chimiques utilisées dans la fabrication pharmaceutique ou médicale ou réalisées dans... |
|
1970
|
G/S
|
Produits chimiques et compositions pour l'industrie
pharmaceutique, chimique, alimentaire, pour ... |
